Apellis Pharmaceuticals Inc (APLS)

07:30 AM

How to monitor Apellis Pharmaceuticals Inc. with trend dashboardsWeekly Investment Summary & Community Consensus Stock Picks - newser.com

07:30 AM

06:19 AM

Volume spikes in Apellis Pharmaceuticals Inc. stock – what they mean2025 Geopolitical Influence & Risk Controlled Daily Trade Plans - newser.com

06:19 AM

05:45 AM

Why retail investors pile into Apellis Pharmaceuticals Inc. stockJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com

05:45 AM

05:43 AM

What MACD and RSI say about Apellis Pharmaceuticals Inc.July 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com

05:43 AM

05:16 AM

What Fibonacci levels say about Apellis Pharmaceuticals Inc. reboundWeekly Stock Recap & AI Driven Price Predictions - newser.com

05:16 AM

Sep 30, 2025

Apellis Pharmaceuticals: Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders - Seeking Alpha

Sep 30, 2025

Sep 30, 2025

Wall Street Has a Mixed Opinion on Apellis Pharmaceuticals (APLS) - MSN

Sep 30, 2025

Sep 30, 2025

What drives Apellis Pharmaceuticals Inc stock priceInstitutional Buying Trends & Free Exceptional Risk Adjusted Gains - earlytimes.in

Sep 30, 2025

Sep 29, 2025

H.C. Wainwright reiterates Buy rating on Apellis Pharmaceuticals stock By Investing.com - Investing.com Canada

Sep 29, 2025

Sep 29, 2025

Apellis Pharmaceuticals CFO sells $16,119 in stock - MSN

Sep 29, 2025

Sep 29, 2025

Published on: 2025-09-29 15:38:29 - newser.com

Sep 29, 2025

Sep 29, 2025

Using R and stats models for Apellis Pharmaceuticals Inc. forecastingQuarterly Trade Review & AI Forecast for Swing Trade Picks - newser.com

Sep 29, 2025

Sep 29, 2025

Can Apellis Pharmaceuticals Inc. stock surprise with earnings upsideQuarterly Profit Review & AI Powered Market Entry Ideas - newser.com

Sep 29, 2025

Sep 29, 2025

Smart tools for monitoring Apellis Pharmaceuticals Inc.’s price actionWeekly Volume Report & Free Community Consensus Stock Picks - newser.com

Sep 29, 2025

Sep 29, 2025

Can Apellis Pharmaceuticals Inc. (1JK) stock sustain institutional flows2025 Historical Comparison & Real-Time Stock Entry Alerts - newser.com

Sep 29, 2025

Sep 29, 2025

Apellis Pharmaceuticals, Inc. $APLS Shares Acquired by Wealth Enhancement Advisory Services LLC - MarketBeat

Sep 29, 2025

Sep 27, 2025

Goldman Sachs downgrades Apellis stock to Sell on Syfovre growth concerns By Investing.com - Investing.com Nigeria

Sep 27, 2025

Sep 26, 2025

12 Analysts Assess Apellis Pharmaceuticals: What You Need To Know - Benzinga

Sep 26, 2025

Sep 26, 2025

Goldman Sachs Downgrades Apellis Pharmaceuticals (APLS) with Low - GuruFocus

Sep 26, 2025

Sep 26, 2025

Goldman Sachs Downgrades Apellis Pharmaceuticals (APLS) Amid Com - GuruFocus

Sep 26, 2025

Sep 26, 2025

Apellis down as Goldman Sachs cuts to sell on risks to outlook - MSN

Sep 26, 2025

Sep 26, 2025

Apellis Pharmaceuticals (NASDAQ:APLS) Shares Gap Down After Analyst Downgrade - MarketBeat

Sep 26, 2025

Sep 26, 2025

Apellis stock cut to sell at Goldman Sachs (APLS:NASDAQ) - Seeking Alpha

Sep 26, 2025

Sep 26, 2025

Apellis Pharmaceuticals (NASDAQ:APLS) Lowered to Sell Rating by The Goldman Sachs Group - MarketBeat

Sep 26, 2025

Sep 26, 2025

Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market SessionApellis Pharmaceuticals (NASDAQ:APLS), Concentrix (NASDAQ:CNXC) - Benzinga

Sep 26, 2025

Sep 26, 2025

Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 26, 2025

Sep 26, 2025

Goldman Sachs Downgrades Apellis Pharmaceuticals to Sell From Neutral, Adjusts PT to $18 From $26 - MarketScreener

Sep 26, 2025

Sep 26, 2025

Goldman Sachs downgrades Apellis stock to Sell on Syfovre growth concerns - Investing.com

Sep 26, 2025

Sep 26, 2025

Fierce Biotech Layoff Tracker 2025: IO lays off 50% of employees; Heidelberg reduces headcount by 75% - Fierce Biotech

Sep 26, 2025

Sep 25, 2025

Apellis Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo

Sep 25, 2025

Sep 23, 2025

Pallas Capital Advisors LLC Has $949,000 Stock Position in Apellis Pharmaceuticals, Inc. $APLS - MarketBeat

Sep 23, 2025

Sep 23, 2025

Apellis Pharmaceuticals (NASDAQ:APLS) Director Sells $713,561.40 in Stock - MarketBeat

Sep 23, 2025

Sep 23, 2025

Zacks Research Has Bullish Estimate for APLS FY2025 Earnings - MarketBeat

Sep 23, 2025

Sep 22, 2025

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Sep 22, 2025

Sep 22, 2025

Apellis Pharmaceuticals (NASDAQ:APLS) General Counsel Sells $121,700.00 in Stock - MarketBeat

Sep 22, 2025

Sep 20, 2025

Setup Watch: Should I invest in ATMV before earningsTreasury Yields & Fast Moving Stock Watchlists - khodrobank.com

Sep 20, 2025

Sep 20, 2025

Dunlop A. Sinclair sells Apellis (APLS) shares worth $713k - Investing.com

Sep 20, 2025

Sep 20, 2025

Goldman Sachs Group Inc. Has $6.73 Million Stake in Apellis Pharmaceuticals, Inc. $APLS - MarketBeat

Sep 20, 2025

Sep 20, 2025

Apellis Pharma director Dunlop sells $713,561 in shares By Investing.com - Investing.com Canada

Sep 20, 2025

Sep 20, 2025

Apellis Pharma director Dunlop sells $713,561 in shares - Investing.com India

Sep 20, 2025

Sep 20, 2025

Dunlop A. Sinclair sells Apellis (APLS) shares worth $713k By Investing.com - Investing.com South Africa

Sep 20, 2025